Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 November 2024 | Story Jacky Tshokwe | Photo Supplied
Kingdom Vision Foundation 2024
The Kingdom Vision Foundation (KVF) management team took part in the annual Social Impact Innovation Awards organised by the SAB Foundation.

In September, the Kingdom Vision Foundation (KVF) management team took part in the annual Social Impact Innovation Awards, organised by the SAB Foundation. This competition included a three-day workshop, during which participants received mentorship on enhancing their business models to maximise sustainable impact. Participants also crafted a four-minute business pitch, which they delivered to a panel of independent judges from sectors such as business, health, education, and government. At the end of the workshop, winners were chosen based on the impact of their innovation, the strength of their business model, and the likelihood of future success.

On 10 October, the management team attended the Innovation Awards Ceremony, where KVF was honoured with the Development Award worth R700 000. In addition to the grant, KVF will participate in a 15-month business coaching and mentorship programme in 2025, through which the SAB Foundation’s coaching team will support them in expanding and scaling their impact across South Africa.

The funding will enhance both the Kovsie Health and Anchor of Hope eye clinics, which are collaborating with the University of the Free State (UFS) Department of Optometry to provide affordable eye care to thousands of students and community members. The project aims to improve the quality of education for Optometry students, helping them experience the positive change they can drive through social impact. KVF’s vision includes a future at Kovsie Health where every student’s visual needs are met, regardless of financial constraints, and a thriving Anchor of Hope clinic that brings the gift of sight and renewed hope to rural communities around Bloemfontein.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept